Ergoteles’s Sabra Healthcare REIT SBRA Stock Holding History

Ergoteles’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-49,683	Closed	-$571K	–	1453
2023 Q1	$571K	Buy	+49,683	New	+$615K	0.02%	689

Other funds holding SBRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ergoteles's SBRA Position: Q2 2023 in Review

Ergoteles sold out of Sabra Healthcare REIT (SBRA) in Q2 2023, closing a stake of 49,683 shares — an estimated $571K sold.

Ergoteles first reported a position in SBRA in Q1 2023 and held it in 1 quarter. The position peaked at $571K in Q1 2023. 325 funds tracked by Wall St. Rank hold SBRA as of Q2 2023.

Ergoteles reported no remaining Sabra Healthcare REIT position as of Q2 2023 after selling out during the quarter.
Ergoteles sold 49,683 Sabra Healthcare REIT shares in Q2 2023, an estimated $571K.
Ergoteles first reported a position in Sabra Healthcare REIT in Q1 2023 and held it in 1 quarter.
Ergoteles's Sabra Healthcare REIT position peaked at $571K in Q1 2023.
325 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.